Literature DB >> 3878413

Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes.

P J Bjorkman, J L Strominger, D C Wiley.   

Abstract

The human histocompatibility antigens HLA-A and HLA-B are polymorphic cell surface glycoproteins encoded by the major histocompatibility complex. These molecules are the major targets for the immune response during tissue transplantation. They are recognized by cytolytic T-lymphocytes during the immune response against virally infected cells, and have been linked to variations in susceptibility to human autoaggressive and neoplastic diseases. To permit a description of the sites of interaction with alloantisera and T-cell receptors, we have begun a three-dimensional structure determination of HLA-A. We report the isomorphous cyrstallization of two antigenic specificities of papain-solubilized HLA-A, A2 and A28. Isoelectric focusing indicates that the well-ordered crystals incorporate the sialic acid microheterogeneity of the oligosaccharides. Crystallographic evidence indicates that the HLA-A molecule has an approximate 2-fold rotational symmetry axis which, combined with biochemical data, suggests that the domains of the molecule are paired alpha 1 to alpha 2 and alpha 3 to beta 2-microglobulin. This domain organization is similar to the arrangement of domains in the Fab and Fc fragments of immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878413     DOI: 10.1016/0022-2836(85)90271-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  The alpha 1 and alpha 2 domains of H-2 class I molecules interact to form unique epitopes.

Authors:  T Kanda; K LaPan; H Takahashi; E Appella; J A Frelinger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Genetic engineering of an H-2Dd/Q10b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants.

Authors:  D H Margulies; A L Ramsey; L F Boyd; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 3.  Engineering soluble major histocompatibility molecules: why and how.

Authors:  D H Margulies; R Lopez; L F Boyd; J McCluskey
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 4.  Functional sites of human class I MHC molecules: paradigms a dozen?

Authors:  P Parham
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 5.  Analysis of structure/function relationships among major histocompatibility complex class I antigens.

Authors:  J A Bluestone
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

6.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db.

Authors:  H Allen; J Fraser; D Flyer; S Calvin; R Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.

Authors:  Kenjiro Kumano; Hitomi Nishinakamura; Toshiyuki Mera; Takeshi Itoh; Hiroyuki Takahashi; Toshiyoshi Fujiwara; Shohta Kodama
Journal:  Islets       Date:  2016-09-02       Impact factor: 2.694

9.  Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy.

Authors:  J C Gorga; A Dong; M C Manning; R W Woody; W S Caughey; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 10.  T cells and their eons-old obsession with MHC.

Authors:  Lei Yin; James Scott-Browne; John W Kappler; Laurent Gapin; Philippa Marrack
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.